Deciphera Pharmaceuticals, Inc. Sublease Income
Deciphera Pharmaceuticals, Inc. reported Sublease Income of $2.93 million for the 12-month period ending 2023-12-31, per its 10-K filed 2024-02-07.
Discontinued › Expense Statement › Operating Expenses
us-gaap:SubleaseIncome · last filed 2024-02-07
- Deciphera Pharmaceuticals, Inc. sublease income for the quarter ending 2022-12-31 was $736.00K.
- Deciphera Pharmaceuticals, Inc. sublease income for the quarter ending 2022-09-30 was $700.00K.
- Deciphera Pharmaceuticals, Inc. sublease income for the quarter ending 2022-06-30 was $300.00K.
- Deciphera Pharmaceuticals, Inc. sublease income for fiscal 2023 was $2.93M, a 68.55% increase from fiscal 2022.
- Deciphera Pharmaceuticals, Inc. sublease income for fiscal 2022 was $1.74M.
- Deciphera Pharmaceuticals, Inc. sublease income for fiscal 2021 was $0.00.
- Deciphera Pharmaceuticals, Inc. sublease income for fiscal 2020 was $0.00.
| Period end | Sublease Income 3 month | Sublease Income 6 month | Sublease Income 9 month | Sublease Income 12 month |
|---|---|---|---|---|
| 2023-12-31 | $2.93M 10-K · filed 2024-02-07 | |||
| 2022-12-31 | $736.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-07 | $1.44M derived: sum of 2 quarters · filed 2024-02-07 | $1.74M derived: sum of 3 quarters · filed 2024-02-07 | $1.74M 10-K · filed 2024-02-07 |
| 2022-09-30 | $700.00K 10-Q · filed 2022-11-03 | $1.00M derived: sum of 2 quarters · filed 2022-11-03 | $1.00M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $300.00K 10-Q · filed 2022-08-04 | $300.00K 10-Q · filed 2022-08-04 | ||
| 2021-12-31 | $0.00 10-K · filed 2024-02-07 | |||
| 2020-12-31 | $0.00 10-K · filed 2023-02-07 |